The exceptions written into the drug control rules

A part made almost entirely of exceptions

Most of the federal drug control regulations describe duties. One short part collects the situations where those duties bend.

It runs to ten sections and covers ground that looks unrelated at first: distributions between practitioners, restocking an ambulance, surrendered drugs, a religious exemption, and prescribing by video.

What ties them together is that each one names something a registrant may do without the registration or paperwork that would otherwise be required.

Reading them as a set is useful, because a claim that something is allowed usually traces back to one of these carve-outs rather than to a general permission.

The sentence that stops a permission from traveling

Before any exception, the part sets a boundary that people routinely get wrong in both directions.

Nothing in these regulations authorizes a person to do anything they are not permitted to do under other federal law, under treaty obligations, or under the law of the state where they want to act.

And the reverse holds as well: "nor shall compliance with such parts be construed as compliance with other Federal or State laws unless expressly provided in such other laws."

So a federal exception is not a state permission, and following the federal rule is not evidence of following anything else.

That matters in a market where the same activity is regulated by a state board, a state pharmacy law and a federal agency at once. Satisfying one of them settles one of them.

Anyone may ask for an exception, and nobody is owed one

A general escape valve exists and is open to everyone. "Any person may apply for an exception to the application of any provision of this chapter by filing a written request", stating the reasons.

The request goes to the agency at the address published in its own table of mailing addresses, which is where the current one lives rather than in the regulation text.

The answer is discretionary in the strongest terms. The Administrator may grant an exception, but "in no case shall he/she be required to grant an exception".

This is worth knowing when a company describes an arrangement as having been cleared. An exception is a specific written grant to a specific applicant, not a category anyone can join.

The five percent rule between practitioners

A practitioner registered to dispense may also distribute a quantity of a controlled substance to another practitioner. The parenthesis in the rule is the whole point: they may do it "may distribute (without being registered to distribute) a quantity of such substance".

Four conditions attach. The receiving practitioner has to be registered to dispense that substance. Both sides record the transfer under the recordkeeping rules. If the substance is in Schedule I or II, an order form is used.

The fourth condition is a ceiling, and it is the one that decides whether a practice needs a second registration. The total dosage units distributed this way in a calendar year must stay inside a share. It "does not exceed 5 percent of the total number of dosage units of all controlled substances distributed and dispensed by the practitioner during the same calendar year."

Crossing it is not a violation to be discovered later. If a practitioner has reason to believe the year will exceed that share, "the practitioner shall obtain a registration to distribute controlled substances."

One category is carved out of the count. Distributions a registered retail pharmacy makes to automated dispensing systems at long term care facilities, where the pharmacy also holds those registrations, do not count toward the limit.

The substance nobody set out to make

A manufacturing exception covers a situation that sounds hypothetical and is not.

A registered manufacturer who "incidentally but necessarily, manufactures a controlled substance" as a result of making something it is registered and quota-approved to make is exempt from registering for the incidental substance.

Where that incidental substance falls in Schedule I or II, the manufacturer is also exempt from needing an individual manufacturing quota for it.

The exemption is conditional on disposal. It applies if the substances are disposed of under the separate disposal rules.

It is a small provision with a general lesson. A byproduct can be a scheduled substance, and the rules handle that by exempting the registration while keeping the disposal duty.

Ambulances, hospitals and emergencies

Two of the newest sections in this part deal with emergency medical services, and both took effect in February 2026.

The first lets a registered emergency medical services agency receive controlled substances from a hospital, without the order form a distribution would normally require. The stated purpose is "for purposes of restocking an emergency medical services vehicle following an emergency response".

Three conditions apply. The agency location keeps a record of the receipt, and the hospital keeps a record of the delivery. The third applies where the vehicle is primarily based at a designated rather than registered location. Then "such location notifies the registered location of the agency within 72 hours of the vehicle receiving the controlled substances."

The second section is broader and is gated on approval rather than on records. Hospitals and emergency services registered and designated locations may deliver controlled substances to each other "with written approval from the Special Agent in Charge of DEA for the area or DEA Headquarters".

Three triggers are listed: shortages of such substances, a public health emergency, or a mass casualty event.

That is a shortage provision written into the drug control rules themselves, which is worth noting on a site where shortage language does a lot of work.

Where surrendered drugs can go

Controlled substances surrendered to the agency or forfeited under the statute do not simply disappear.

They may be delivered to any federal or state department, bureau or agency on a proper written application.

The application has to name the person or agency receiving them, their official title, the substance and quantity wanted, and the purpose intended.

Delivery is ordered by the Administrator "if, in his opinion, there exists a medical or scientific need therefor."

It is a narrow route and a government-to-government one. Nothing here describes a way for a private party to obtain surrendered stock.

The religious exemption, and its limit

One section deals with peyote and the Native American Church, and it is precise about which side of the transaction is exempt.

The Schedule I listing "does not apply to the nondrug use of peyote in bona fide religious ceremonies of the Native American Church", and members using it that way are exempt from registration.

The supply side is not exempt. Any person who manufactures peyote for, or distributes it to, the Church "is required to obtain registration annually and to comply with all other requirements of law."

That split is the general shape of exemptions in this area. Use can be excepted while manufacture and distribution stay fully regulated.

The telemedicine authority, and the date printed on it

The section most relevant to anyone buying medicine online is also the one with an expiry date written into its first paragraph.

"This section is in effect until the end of the day December 31, 2026." The authorization it grants expires at the end of that day.

What it authorizes is significant. During the stated period a registered practitioner "is authorized to prescribe schedule II-V controlled substances via telemedicine" to a patient. The rule adds that this may be done "without having conducted an in-person medical evaluation of the patient if all of the conditions listed in paragraph (c) of this section are met."

Four conditions are listed. The prescription must be issued "for a legitimate medical purpose by a practitioner acting in the usual course of professional practice".

It must be issued after a communication "using an interactive telecommunications system" of the kind the referenced health care regulation describes.

The practitioner must be authorized under their registration to prescribe that class of substance, or exempt from needing a registration. And the prescription must satisfy all the other prescribing requirements that apply anyway.

The source text also carries an effective date note recording that the section was revised effective the first day of 2026 through the last day of 2026. What happens after that is not stated in the regulation, and nothing here predicts it.

Reading this against a real purchase

Three of these sections change how a reader should hear common marketing language.

The interactive telecommunications condition is the one to hold onto. Where a controlled substance is involved, this authority is built on a real-time exchange, not on a form.

The five percent rule explains why a clinic cannot casually supply another clinic at scale. Past a defined share of its own annual volume, it needs a distributor registration.

And the opening boundary section is the reason a federal permission never settles a state question by itself.

One limit on this article. Only part 1307 was read, and the definition section was left aside because it only points to definitions kept elsewhere. The parts it cross-references, on registration, records, quotas, prescriptions and disposal, were not read for this piece.

Most peptides discussed on this site are not controlled substances at all, so none of this reaches them. It reaches the scheduled products a telehealth practice may also prescribe.

Sources

Each document below is named as it names itself, with the date printed on that document rather than the day it was read.

1. Title 21 Code of Federal Regulations section 1307.02, Application of State law and other Federal law, read in full — Electronic Code of Federal Regulations, Office of the Federal Register, March 1997
2. Title 21 Code of Federal Regulations section 1307.03, Exceptions to regulations, read in full for who may apply and the discretionary standard — Electronic Code of Federal Regulations, Office of the Federal Register, March 2010
3. Title 21 Code of Federal Regulations section 1307.11, Distribution by dispenser to another practitioner, read in full for the four conditions, the five percent ceiling and the long term care carve-out — Electronic Code of Federal Regulations, Office of the Federal Register, September 2014
4. Title 21 Code of Federal Regulations section 1307.13, Incidental manufacture of controlled substances, read in full — Electronic Code of Federal Regulations, Office of the Federal Register, September 2014
5. Title 21 Code of Federal Regulations section 1307.14, Delivery of controlled substances to designated locations of emergency medical services agencies, read in full for the restocking exception and the seventy-two hour notification — Electronic Code of Federal Regulations, Office of the Federal Register, February 2026
6. Title 21 Code of Federal Regulations section 1307.15, Delivery of controlled substances in emergency situations, read in full for the written approval requirement and the three triggers — Electronic Code of Federal Regulations, Office of the Federal Register, February 2026
7. Title 21 Code of Federal Regulations section 1307.22, Delivery of surrendered and forfeited controlled substances, read in full for the application contents and the medical or scientific need standard — Electronic Code of Federal Regulations, Office of the Federal Register, September 2014
8. Title 21 Code of Federal Regulations section 1307.31, Native American Church, read in full for the use exemption and the manufacture and distribution requirement — Electronic Code of Federal Regulations, Office of the Federal Register, September 1973
9. Title 21 Code of Federal Regulations section 1307.41, Temporary extension of certain COVID-19 telemedicine flexibilities for prescription of controlled medications, read in full for the stated expiry, the authorization and the four conditions, together with its effective date note — Electronic Code of Federal Regulations, Office of the Federal Register, December 2025